Bacterial cell wall assembly

Bacterial cell wall assembly refers to the **multi-step biochemical process** responsible for constructing the rigid exoskeleton that surrounds most bacteria. The primary component synthesized during this process is **peptidoglycan**—a mesh-like polymer composed of alternating N-acetylglucosamine and N-acetylmuramic acid sugars cross-linked by short peptide chains[1][2][3][4]. This structure provides mechanical strength necessary to withstand internal turgor pressure and maintain cellular shape. The composition and architecture vary between Gram-positive and Gram-negative bacteria but always involve tightly regulated enzymatic pathways that are essential for growth and survival[1][2][3]. Disruption at any stage—by genetic mutation or pharmacologic inhibition—leads to loss of viability due to osmotic lysis. Because humans lack peptidoglycan-based structures entirely, these pathways have been highly successful targets for antibiotic development[5].

Other names

Peptidoglycan biosynthesisCell wall biogenesisMurein synthesis

Drugs targeting bacterial cell wall assembly typically act by inhibiting key enzymatic steps such as: - Inhibition of transpeptidase activity (cross-linking peptides in peptidoglycan) by beta-lactams[5] - Inhibition of glycosyltransferase activity by glycopeptides like vancomycin[5] These actions prevent proper formation or cross-linking of the peptidoglycan layer, leading to loss of structural integrity and bacterial death.